Search
Organogenesis Holdings Inc
ORGOAdd to Watchlist
2.370USD
-0.080-3.27%
Close 07-31 16:00（ET）Quotes delayed by 15 min
304.96MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Organogenesis Holdings Inc is 6.00, ranking 331 out of 385 in the Biotechnology & Medical Research industry. The average price target is 8.50, with a high of 9.00 and a low of 8.00.
Analyst Rating
Based on
2
analysts
Hold
Current Rating
3.000
Target Price
+26.58%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Organogenesis Holdings Inc
ORGO
2
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Organogenesis Holdings Inc's expected revenue for the next quarter?
Organogenesis Holdings Inc's expected revenue is 54.25M.
What is Organogenesis Holdings Inc's price target?
Analysts forecast that Organogenesis Holdings Inc's price target is USD 8.50, with the highest forecast at USD 9.00 and the lowest forecast at USD 8.00.
How have Organogenesis Holdings IncORGO's recent earnings per share performed?
The market expectation was USD -0.44, while Organogenesis Holdings IncORGO's earnings per share (EPS) for the previous quarter was USD 0.28. EPS for the next quarter is expected at USD -0.35.
What is the analyst rating for Organogenesis Holdings Inc?
Based on the ratings of Organogenesis Holdings Inc's stock from 2 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.